Market cap
₹38 Cr
Revenue (TTM)
₹116 Cr
P/E Ratio
181.7
P/B Ratio
0.7
Div. Yield
0 %
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
38 | 14,717 | 9,559 | 7,760 | 5,228 |
Revenue (₹ Cr) |
116 | 9,798 | 4,172 | 1,644 | 3,775 |
Net Profit (₹ Cr) |
0.21 | 422.82 | 207.16 | 209.82 | -709.87 |
Net Margin (%) |
0.18 | 4.29 | 4.21 | 12.43 | -18.45 |
RoE (%) |
2.08 | 11.13 | 2.99 | 16.61 | -- |
Price to Earnings |
181.68 | 35.54 | 42.75 | 36.94 | -- |
Price-To-Book |
0.67 | 3.20 | 1.27 | 5.93 | -0.24 |
Income Statement (₹ Cr)
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
|
Operating Revenue
|
116.09 | 9,797.83 | 4,171.76 | 1,643.93 | 3,775.41 |
|
Total Income
|
117.68 | 9,863.09 | 4,919.15 | 1,687.71 | 3,847.76 |
|
Total Expenditure
|
111.62 | 8,730.44 | 4,406.13 | 1,338.35 | 3,709.42 |
|
EBITDA
|
4.47 | 1,067.39 | -234.37 | 305.58 | 65.99 |
|
Depreciation
|
1.58 | 314.45 | 124.37 | 36.37 | 261.86 |
|
EBIT
|
2.89 | 752.94 | -358.74 | 269.21 | -195.87 |
|
Interest
|
2.75 | 178.02 | 93.43 | 13.73 | 609.76 |
|
Other Income
|
1.59 | 65.26 | 747.39 | 43.78 | 72.35 |
|
Exceptional Items
|
-1.13 | -39.84 | 0.00 | -13.90 | 22.39 |
|
Profit before Tax
|
0.60 | 600.34 | 295.22 | 285.36 | -710.89 |
|
Provision for Tax
|
0.39 | 177.52 | 88.06 | 75.54 | -1.02 |
|
Profit after Tax
|
0.21 | 422.82 | 207.16 | 209.82 | -709.87 |
Liabilities (₹ Cr)
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
55.58 | 4,044.19 | 7,536.40 | 1,354.42 | -21,527.79 |
|
Minority Interest
|
0.00 | -15.89 | 15.29 | -0.07 | 0.00 |
|
Non-Current Liabilities
|
18.37 | 801.89 | 1,781.20 | 89.04 | 25,653.08 |
|
Current Liabilities
|
37.21 | 3,893.11 | 2,877.08 | 435.28 | 2,349.26 |
|
Total Liabilities
|
100.58 | -- | 13,603.50 | 1,756.62 | 6,729.87 |
Assets (₹ Cr)
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
20.52 | 3,995.73 | 7,932.44 | 638.02 | 4,794.69 |
|
Current Assets
|
78.41 | 4,441.27 | 5,487.27 | 1,191.65 | 1,439.38 |
|
Total Assets
|
100.58 | -- | 13,603.50 | 1,756.62 | 6,729.87 |
|
Total Debt*
|
26.50 | 1,375.96 | 2,823.49 | 61.42 | 25,960.25 |
|
Net Current Assets
|
41.20 | 548.16 | 2,610.20 | 756.37 | -909.88 |
|
Contingent Liabilities
|
1.05 | 46.83 | 1,262.43 | 8.91 | 0.86 |
Cashflow (₹ Cr)
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-13.72 | 762.88 | -528.86 | 196.12 | 115.22 |
|
Cash Flow from Investing Activities
|
4.50 | -503.53 | 1,345.52 | 10.29 | 276.58 |
|
Cash from Financing Activities
|
12.23 | -270.92 | -559.76 | -331.83 | -347.68 |
|
Net Cash Inflow / Outflow
|
3.00 | -11.57 | 256.89 | -125.42 | 44.12 |
Ratios
Profitability Ratios
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
|
ROCE (%)
|
11.43 | 13.98 | 16.64 | 24.74 | -3.17 |
|
ROE (%)
|
2.08 | 11.13 | 2.99 | 16.61 | 0.00 |
|
ROA (%)
|
0.20 | 4.99 | 1.51 | 11.54 | -10.75 |
|
EBIT Margin (%)
|
2.49 | 7.68 | -8.60 | 16.38 | -5.19 |
|
Net Margin (%)
|
0.18 | 4.29 | 4.21 | 12.43 | -18.45 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-6.70 | 15.21 | -16.72 | 4.64 | 3.86 |
|
EBIT Growth (%)
|
-24.42 | 21.12 | 44.41 | -8.26 | 48.35 |
|
Net Profit Growth (%)
|
-92.66 | 11.39 | -67.27 | -11.79 | 9.01 |
|
EPS Growth (%)
|
-66.82 | 19.25 | -64.96 | -55.89 | 18.65 |
|
Book Value Growth (%)
|
165.16 | 6.76 | 16.94 | 0.62 | -4.32 |
Valuation Ratios
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
|
Price / Earnings
|
32.34 | 32.33 | 42.75 | 35.64 | -7.13 |
|
Price / Book Value
|
0.67 | 3.20 | 1.27 | 5.93 | -0.24 |
|
Dividend Yield (%)
|
0.00 | 0.83 | 0.05 | 1.13 | 0.00 |
|
EV/EBITDA
|
13.68 | 14.77 | -43.92 | 24.15 | 472.96 |
|
Market Cap (₹ Cr)
|
237.01 | 8,252.18 | 13,476.92 | 8,572.11 | 7,482.46 |
Solvency Ratios
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.24 | 0.07 | 0.19 | 0.01 | -1.19 |
|
Short term debt to equity ratio
|
0.34 | 0.26 | 0.11 | 0.05 | -0.01 |
|
Current Ratio
|
2.11 | 1.14 | 1.91 | 2.74 | 0.61 |
|
Quick Ratio
|
1.55 | 0.58 | 1.49 | 1.82 | 0.24 |
|
Interest Coverage
|
1.22 | 4.37 | 4.16 | 21.79 | -0.17 |
Operating Efficiency Ratios
| Trident Texofab | Arvind | Swan | Garware Technical | Alok | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
41.82 | 14.74 | 53.83 | 16.83 | 8.43 |
|
Asset Turnover
|
1.10 | 1.16 | 0.30 | 0.90 | 0.57 |
|
Receivable days
|
115.01 | 48.13 | 120.76 | 68.03 | 44.32 |
|
Inventory Days
|
43.85 | 88.33 | 70.31 | 61.82 | 88.61 |
|
Payable days
|
54.41 | 95.29 | 44.06 | 203.87 | 85.56 |
|
Cash Conversion Cycle
|
104.45 | 41.17 | 147.02 | -74.01 | 47.37 |